Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride boosts immune cells that suppress T-cells, possibly helping with immune disorders but may increase cancer risk.

Using a niacinamide cream can improve life quality for breast cancer patients during chemotherapy.

Most pediatric cancer patients at Muhimbili National Hospital experienced adverse drug reactions during chemotherapy, highlighting the need for careful monitoring.

The MDR1 C3435T polymorphism does not significantly affect methotrexate response in rheumatoid arthritis patients.

Cyclophosphamide can cause serious short-term and long-term side effects, including increased cancer risk and infertility.

Chemotherapy causes permanent hair follicle damage by triggering stem cell loss.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Afatinib often causes skin problems that need proactive management.

Minoxidil helps treat severe high blood pressure.

Finasteride linked to skin inflammation.

Tofacitinib is effective and safe for treating alopecia areata.

The FDA approved a new Pfizer drug for hair loss in teens.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

A new microneedle patch effectively promotes hair regrowth with less frequent dosing.

Copper-doxorubicin nanoparticles effectively treat tumors with less toxicity.

A woman with a rare type of dermatomyositis improved with low-dose prednisone and methotrexate.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

Upadacitinib effectively treated severe hair loss in a child.

Baricitinib is effective as a treatment for severe hair loss.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

JAK inhibitors show promise for treating various skin diseases.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.